Results 191 to 200 of about 138,715 (220)

Modifiable Lifestyle Risk Factors and Strategies for Slowing the Progression of Age-Related Macular Degeneration. [PDF]

Vision (Basel)
Saigal K, Salama JE, Pardo AA, Lopez SE, Gregori NZ.   +4 more
europepmc   +1 more source

Fluorescence Lifetime Imaging Ophthalmoscopy, Vision, and Chorioretinal Asymmetries in Aging and Age-Related Macular Degeneration: ALSTAR2. [PDF]

Invest Ophthalmol Vis Sci
Goerdt L, Clark ME, Thomas TN, Gao L, McGwin G, Hammer M, Crosson JN, Sloan KR, Owsley C, Curcio CA.   +9 more
europepmc   +1 more source

Dry and neovascular "wet" age-related macular degeneration: Upcoming therapies. [PDF]

Indian J Ophthalmol
Yan A, Hasan N, Chhablani J.
europepmc   +1 more source

Risk factors for age-related macular degeneration: Updated systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Babaker R, Alzimami L, Al Ameer A, Almutairi M, Alam Aldeen R, Alshatti H, Al-Johani N, Al Taisan A.   +7 more
europepmc   +1 more source

Machine learning model for age related macular degeneration based on pesticides: the National Health and Nutrition Examination Survey 2007-2008. [PDF]

Front Public Health
Liu J, Wang B, Li Q.
europepmc   +1 more source

Intravitreal Faricimab for Previously Treated Neovascular Age-Related Macular Degeneration. [PDF]

Clin Ophthalmol
Hang A, Ngo T, Virk JS, Moussa K, Moshiri A, Emami-Naeini P, Park SS.   +6 more
europepmc   +1 more source

A cross-sectional observational study of the association between biochemistry profiles and the risk of age-related macular degeneration. [PDF]

Sci Rep
Bai S, Zhang L, Yan W, Wang H.
europepmc   +1 more source

Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration. [PDF]

Br J Ophthalmol
Zur D, Guymer R, Korobelnik JF, Wu L, Viola F, Eter N, Baillif S, Chen Y, Arnold JJ.   +8 more
europepmc   +1 more source